Literature DB >> 16986161

The admixture maximum likelihood test: a novel experiment-wise test of association between disease and multiple SNPs.

Jonathan Tyrer1, Paul D P Pharoah, Douglas F Easton.   

Abstract

Disease association studies often test large numbers of markers, and various methods have been proposed to correct for multiple testing. In this paper, we propose an admixture maximum likelihood approach that estimates both the proportion of associated single nucleotide polymorphisms (SNPs) and their typical effect size. We assessed this method and compared it with several previously proposed approaches by simulation. The maximum likelihood approach performed similarly to or better than all other tests across a wide range of alternative hypotheses. The rank truncated product method also had good power, though somewhat inferior to the maximum likelihood approach in most cases. A simple Bonferroni correction performed best only when the number of associated SNPs was small. (c) 2006 Wiley-Liss, Inc.

Mesh:

Year:  2006        PMID: 16986161     DOI: 10.1002/gepi.20175

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  21 in total

1.  A Bayesian measure of the probability of false discovery in genetic epidemiology studies.

Authors:  Jon Wakefield
Journal:  Am J Hum Genet       Date:  2007-07-03       Impact factor: 11.025

2.  Genetic associations with sporadic neuroendocrine tumor risk.

Authors:  Monica Ter-Minassian; Zhaoxi Wang; Kofi Asomaning; Michael C Wu; Chen-Yu Liu; Jessica K Paulus; Geoffrey Liu; Penelope A Bradbury; Rihong Zhai; Li Su; Christine S Frauenhoffer; Susanne M Hooshmand; Immaculata De Vivo; Xihong Lin; David C Christiani; Matthew H Kulke
Journal:  Carcinogenesis       Date:  2011-05-23       Impact factor: 4.944

3.  Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.

Authors:  Genevieve M Monsees; Peter Kraft; Stephen J Chanock; David J Hunter; Jiali Han
Journal:  Breast Cancer Res Treat       Date:  2010-05-23       Impact factor: 4.872

4.  Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer.

Authors:  Jingmei Li; Louise Eriksson; Keith Humphreys; Kamila Czene; Jianjun Liu; Rulla M Tamimi; Sara Lindström; David J Hunter; Celine M Vachon; Fergus J Couch; Christopher G Scott; Pagona Lagiou; Per Hall
Journal:  Breast Cancer Res       Date:  2010-03-09       Impact factor: 6.466

5.  Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.

Authors:  Yen Ling Low; Yuqing Li; Keith Humphreys; Anbupalam Thalamuthu; Yi Li; Hatef Darabi; Sara Wedrén; Carine Bonnard; Kamila Czene; Mark M Iles; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Heli Nevanlinna; Per Hall; Edison T Liu; Jianjun Liu
Journal:  PLoS Genet       Date:  2010-07-01       Impact factor: 5.917

6.  Evidence of a genetic link between endometriosis and ovarian cancer.

Authors:  Alice W Lee; Claire Templeman; Douglas A Stram; Jonathan Beesley; Jonathan Tyrer; Andrew Berchuck; Paul P Pharoah; Georgia Chenevix-Trench; Celeste Leigh Pearce
Journal:  Fertil Steril       Date:  2015-10-23       Impact factor: 7.329

7.  Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.

Authors:  Jennifer B Permuth; Ailith Pirie; Y Ann Chen; Hui-Yi Lin; Brett M Reid; Zhihua Chen; Alvaro Monteiro; Joe Dennis; Gustavo Mendoza-Fandino; Hoda Anton-Culver; Elisa V Bandera; Maria Bisogna; Louise Brinton; Angela Brooks-Wilson; Michael E Carney; Georgia Chenevix-Trench; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Cezary Cybulski; Aimee A D'Aloisio; Jennifer Anne Doherty; Madalene Earp; Robert P Edwards; Brooke L Fridley; Simon A Gayther; Aleksandra Gentry-Maharaj; Marc T Goodman; Jacek Gronwald; Estrid Hogdall; Edwin S Iversen; Anna Jakubowska; Allan Jensen; Beth Y Karlan; Linda E Kelemen; Suzanne K Kjaer; Peter Kraft; Nhu D Le; Douglas A Levine; Jolanta Lissowska; Jan Lubinski; Keitaro Matsuo; Usha Menon; Rosemary Modugno; Kirsten B Moysich; Toru Nakanishi; Roberta B Ness; Sara Olson; Irene Orlow; Celeste L Pearce; Tanja Pejovic; Elizabeth M Poole; Susan J Ramus; Mary Anne Rossing; Dale P Sandler; Xiao-Ou Shu; Honglin Song; Jack A Taylor; Soo-Hwang Teo; Kathryn L Terry; Pamela J Thompson; Shelley S Tworoger; Penelope M Webb; Nicolas Wentzensen; Lynne R Wilkens; Stacey Winham; Yin-Ling Woo; Anna H Wu; Hannah Yang; Wei Zheng; Argyrios Ziogas; Catherine M Phelan; Joellen M Schildkraut; Andrew Berchuck; Ellen L Goode; Paul D P Pharoah; Thomas A Sellers
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

8.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

9.  Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.

Authors:  Kristy E Driver; Honglin Song; Fabienne Lesueur; Shahana Ahmed; Nuno L Barbosa-Morais; Jonathan P Tyrer; Bruce A J Ponder; Douglas F Easton; Paul D P Pharoah; Alison M Dunning
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

10.  No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

Authors:  Lara E Sucheston-Campbell; Rikki Cannioto; Alyssa I Clay; John Lewis Etter; Kevin H Eng; Song Liu; Sebastiano Battaglia; Qiang Hu; J Brian Szender; Albina Minlikeeva; Janine M Joseph; Paul Mayor; Scott I Abrams; Brahm H Segal; Paul K Wallace; Kah Teong Soh; Emese Zsiros; Hoda Anton-Culver; Elisa V Bandera; Matthias W Beckmann; Andrew Berchuck; Line Bjorge; Amanda Bruegl; Ian G Campbell; Shawn Patrice Campbell; Georgia Chenevix-Trench; Daniel W Cramer; Agnieszka Dansonka-Mieszkowska; Fanny Dao; Brenda Diergaarde; Thilo Doerk; Jennifer A Doherty; Andreas du Bois; Diana Eccles; Svend Aage Engelholm; Peter A Fasching; Simon A Gayther; Aleksandra Gentry-Maharaj; Rosalind M Glasspool; Marc T Goodman; Jacek Gronwald; Philipp Harter; Alexander Hein; Florian Heitz; Peter Hillemmanns; Claus Høgdall; Estrid V S Høgdall; Tomasz Huzarski; Allan Jensen; Sharon E Johnatty; Audrey Jung; Beth Y Karlan; Reudiger Klapdor; Tomasz Kluz; Bożena Konopka; Susanne Krüger Kjær; Jolanta Kupryjanczyk; Diether Lambrechts; Jenny Lester; Jan Lubiński; Douglas A Levine; Lene Lundvall; Valerie McGuire; Iain A McNeish; Usha Menon; Francesmary Modugno; Roberta B Ness; Sandra Orsulic; James Paul; Celeste Leigh Pearce; Tanja Pejovic; Paul Pharoah; Susan J Ramus; Joseph Rothstein; Mary Anne Rossing; Matthias Rübner; Joellen M Schildkraut; Barbara Schmalfeldt; Ira Schwaab; Nadeem Siddiqui; Weiva Sieh; Piotr Sobiczewski; Honglin Song; Kathryn L Terry; Els Van Nieuwenhuysen; Adriaan Vanderstichele; Ignace Vergote; Christine S Walsh; Penelope M Webb; Nicolas Wentzensen; Alice S Whittemore; Anna H Wu; Argyrios Ziogas; Kunle Odunsi; Jenny Chang-Claude; Ellen L Goode; Kirsten B Moysich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-09-27       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.